Stages of Adoption of 'Treatment as Prevention' Among HIV-Negative Men Who Have Sex with Men Who Engage in Exchange Sex
Autor: | Eric W. Schrimshaw, Karolynn Siegel, Anne E Sundelson, Étienne Meunier |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Anti-HIV Agents Human immunodeficiency virus (HIV) HIV Infections medicine.disease_cause Men who have sex with men Sexual and Gender Minorities 03 medical and health sciences 0302 clinical medicine HIV Seronegativity Humans Medicine 030212 general & internal medicine Homosexuality Male Hiv treatment 030505 public health business.industry Clinical and Epidemiologic Research Public Health Environmental and Occupational Health virus diseases Viral Load Treatment as prevention Sexual Partners Infectious Diseases Pre-Exposure Prophylaxis 0305 other medical science business Demography |
Zdroj: | AIDS Patient Care STDS |
ISSN: | 1557-7449 1087-2914 |
Popis: | Prior research found low acceptability of HIV treatment as prevention (TasP; or Undetectable = Untransmittable) among HIV-negative men who have sex with men (MSM). This study reports on qualitative data regarding TasP adoption in a sample of 170 self-reported HIV-negative MSM who had engaged in exchange sex (received money, drugs, or other things in exchange for sex). We classified participants along five stages of TasP adoption: 1–unaware of TasP (11.2%); 2–aware, but perceived ineffective (17.1%); 3–perceived effective, but unwilling to use (35.3%); 4–willing to rely on TasP, but had never done so (24.1%); and 5–had relied on TasP (12.4%). Obstacles to TasP adoption included the following: not believing that it could completely prevent HIV transmission; deeply ingrained fears of HIV/AIDS; concerns about viral load fluctuation; and reluctance to trust a partner's claimed undetectable status. TasP promotion efforts, which can decrease barriers to HIV testing and HIV stigma, will be more effective if tailored to the obstacles specific to each stage of TasP adoption. |
Databáze: | OpenAIRE |
Externí odkaz: |